Global Biosimilars/follow-on-biologics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Human growth hormone
  • 1.4.3 Erythropoietin
  • 1.4.4 Monoclonal antibodies
  • 1.4.5 Insulin
  • 1.4.6 Interferon
  • 1.4.7 Granulocyte-Colony Stimulating Factor
  • 1.4.8 Others
• 1.5 Market by Application
  • 1.5.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
  • 1.5.2 Blood disorders
  • 1.5.3 Oncology diseases
  • 1.5.4 Chronic and autoimmune diseases
  • 1.5.5 Growth hormone deficiencies
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Biosimilars/follow-on-biologics Market Perspective (2015-2026)
• 2.2 Global Biosimilars/follow-on-biologics Growth Trends by Regions
  • 2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biosimilars/follow-on-biologics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biosimilars/follow-on-biologics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biosimilars/follow-on-biologics Players by Market Size
  • 3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2015-2020)
  • 3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biosimilars/follow-on-biologics Market Concentration Ratio
  • 3.2.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2019
• 3.3 Biosimilars/follow-on-biologics Key Players Head office and Area Served
• 3.4 Key Players Biosimilars/follow-on-biologics Product Solution and Service
• 3.5 Date of Enter into Biosimilars/follow-on-biologics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2015-2020)
• 4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
• 5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biosimilars/follow-on-biologics Market Size (2015-2020)
• 6.2 Biosimilars/follow-on-biologics Key Players in North America (2019-2020)
• 6.3 North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 6.4 North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biosimilars/follow-on-biologics Market Size (2015-2020)
• 7.2 Biosimilars/follow-on-biologics Key Players in Europe (2019-2020)
• 7.3 Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 7.4 Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

8 China

• 8.1 China Biosimilars/follow-on-biologics Market Size (2015-2020)
• 8.2 Biosimilars/follow-on-biologics Key Players in China (2019-2020)
• 8.3 China Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 8.4 China Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biosimilars/follow-on-biologics Market Size (2015-2020)
• 9.2 Biosimilars/follow-on-biologics Key Players in Japan (2019-2020)
• 9.3 Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 9.4 Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2015-2020)
• 10.2 Biosimilars/follow-on-biologics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

11 India

• 11.1 India Biosimilars/follow-on-biologics Market Size (2015-2020)
• 11.2 Biosimilars/follow-on-biologics Key Players in India (2019-2020)
• 11.3 India Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 11.4 India Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biosimilars/follow-on-biologics Market Size (2015-2020)
• 12.2 Biosimilars/follow-on-biologics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
• 12.4 Central & South America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Novartis (Sandoz)
  • 13.1.1 Novartis (Sandoz) Company Details
  • 13.1.2 Novartis (Sandoz) Business Overview
  • 13.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
  • 13.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020))
  • 13.1.5 Novartis (Sandoz) Recent Development
• 13.2 Synthon Pharmaceuticals
  • 13.2.1 Synthon Pharmaceuticals Company Details
  • 13.2.2 Synthon Pharmaceuticals Business Overview
  • 13.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
  • 13.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.2.5 Synthon Pharmaceuticals Recent Development
• 13.3 Teva Pharmaceutical Industries
  • 13.3.1 Teva Pharmaceutical Industries Company Details
  • 13.3.2 Teva Pharmaceutical Industries Business Overview
  • 13.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
  • 13.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.3.5 Teva Pharmaceutical Industries Recent Development
• 13.4 LG Life Sciences
  • 13.4.1 LG Life Sciences Company Details
  • 13.4.2 LG Life Sciences Business Overview
  • 13.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
  • 13.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.4.5 LG Life Sciences Recent Development
• 13.5 Celltrion Biocon
  • 13.5.1 Celltrion Biocon Company Details
  • 13.5.2 Celltrion Biocon Business Overview
  • 13.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
  • 13.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.5.5 Celltrion Biocon Recent Development
• 13.6 Hospira
  • 13.6.1 Hospira Company Details
  • 13.6.2 Hospira Business Overview
  • 13.6.3 Hospira Biosimilars/follow-on-biologics Introduction
  • 13.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.6.5 Hospira Recent Development
• 13.7 Merck Serono (Merck)
  • 13.7.1 Merck Serono (Merck) Company Details
  • 13.7.2 Merck Serono (Merck) Business Overview
  • 13.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
  • 13.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.7.5 Merck Serono (Merck) Recent Development
• 13.8 Biogen idec
  • 13.8.1 Biogen idec Company Details
  • 13.8.2 Biogen idec Business Overview
  • 13.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
  • 13.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.8.5 Biogen idec Recent Development
• 13.9 Genentech (Roche)
  • 13.9.1 Genentech (Roche) Company Details
  • 13.9.2 Genentech (Roche) Business Overview
  • 13.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
  • 13.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
  • 13.9.5 Genentech (Roche) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer